Eden C Payabyab,Lindsay S Elbaum,Navneet Sharma et al.
Eden C Payabyab et al.
Transcatheter aortic valve replacement (TAVR) has become a widely adopted treatment modality for severe aortic stenosis. Transfemoral access is the approach of choice; however, approximately 25% of patients undergoing TAVR also have concomi...
Mixed-Valve Disease: Management of Patients with Aortic Stenosis and Mitral Regurgitation: Thresholds for Surgery Versus Percutaneous Therapies [0.03%]
混合瓣膜疾病：主动脉狭窄和二尖瓣反流患者的管理：手术与经皮介入治疗的阈值
Jean-Bernard Masson,Jessica Forcillo
Jean-Bernard Masson
Significant mitral regurgitation (MR), frequently seen in the presence of severe aortic stenosis (AS), results in an association that negatively affects prognosis and imposes particular challenges for both the assessment of the severity of ...
Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment [0.03%]
复杂经皮冠状动脉介入治疗的抗栓策略-类型和疗程选择
Despoina-Rafailia Benetou,Charalampos Varlamos,Christos Pappas et al.
Despoina-Rafailia Benetou et al.
Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implanta...
Leah A John,Ahmadreza Karimianpour,Michael R Gold
Leah A John
The ICD is an important therapy in the prevention of sudden cardiac death. The transvenous-ICD (TV-ICD) has been the primary device used for this purpose. However, mechanical and infectious complications occur with traditional TV-ICDs incre...
Carlos Vazquez-Sosa,Stacey D Clegg,James C Blankenship
Carlos Vazquez-Sosa
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption of PFO closure excluded patie...
Alexander G Truesdell
Alexander G Truesdell
Editorial
US cardiology. 2021 Nov 26:15:e24. DOI:10.15420/usc.2020.28 2021
Jiaqian Xu,Michael D Shapiro
Jiaqian Xu
Recent scientific and therapeutic advances in proprotein convertase subtilisin kexin type 9 (PCSK9) inhibition have opened a chapter in the management of hypercholesterolemia, especially in patients who are inadequately controlled on or int...
Tanawan Riangwiwat,James C Blankenship
Tanawan Riangwiwat
Transradial access has been increasingly adopted for cardiac catheterization. It is crucial for operators to recognize potential vascular complications associated with radial artery access. Prevention, early detection, and prompt treatment ...
Iosif Xenogiannis,Charalambos Varlamos,Despoina-Rafailia Benetou et al.
Iosif Xenogiannis et al.
Chronic total occlusion (CTO) recanalization is among the most complex subsets of coronary interventions. Hence, optimum peri- and postprocedural anticoagulation and antiplatelet therapy is key for the achievement of successful revasculariz...
Ashleigh Long,Amin Yehya,Kelly Stelling et al.
Ashleigh Long et al.
Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing array of percutaneous mechanical circulatory support devices. Mortality for cardiogenic shock has not changed meaningfully in more than 20 year...